ArticleFrontiers in oncology2024

RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides.

Maria Danielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.